UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to or ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURI ...

Q4 and full-year 2021 results Exceeded outlook with strong performance from non-COVID product groups Q4 and Full-year 2021 results Sample to Insight Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be, deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. ...

QIAGEN N.V. (NYSE:QGEN) Q4 2021 Earnings Conference Call February 9, 2022 9:00 AM ET Company Participants John Gilardi - Vice President of Corporate Communications & Investor Relations Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Tycho Peterson - JPMorgan Daniel Wendorff - ODDO BHF Jack Meehan - Nephron Research Dan Arias - Stifel Falko Friedrichs - Deutsche Bank Operator Please standby, we're about to begin. Ladies a ...

Sample to Insight | --- | --- | --- | --- | |-------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Emerging from change | | | | | with a strengthened profile | | | | | J.P. Morgan Healthcare Conference January 2022 | | | | | Thierry Bernard Chief Executive Officer | | | | Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements ...

QIAGEN N.V. (NYSE:QGEN) Q3 2021 Earnings Conference Call November 4, 2021 9:30 AM ET Company Participants John Gilardi - Vice President, Head-Corporate Communications and Investor Relations Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Falko Friedrichs - Deutsche Bank Tycho Peterson - JPMorgan Daniel Wendorff - Oddo BHF Derik de Bruin - Bank of America Scott Bardo - Berenberg Jack Meehan - Nephron Dan Brennan - Cowen Operator Ladies and gentl ...

Sample to Insight Investor Presentation Q2 2021 Thierry Bernard Chief Executive Officer Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be, deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent t ...

QIAGEN N.V. (NYSE:QGEN) Q1 2021 Earnings Conference Call May 4, 2021 9:00 AM ET Company Participants John Gilardi – Vice President, Head-Corporate Communications and Investor Relations Thierry Bernard – Chief Executive Officer Roland Sackers – Chief Financial Officer Phoebe Loh – Senior Director-Investor Relations Conference Call Participants Patrick Donnelly – Citi Daniel Wendorff – Commerzbank Scott Bardo – Berenberg Doug Schenkel – Cowen John Sourbeer – UBS Falko Friedrichs – Deutsche Bank Brian Weinstei ...

Sample to Insight First quarter 2021 results May 4, 2021 Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be, deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent that any of the statements conta ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to or ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURI ...

QIAGEN N.V. (NYSE:QGEN) Q4 2020 Earnings Conference Call February 10, 2021 9:00 AM ET Company Participants John Gilardi - Vice President, Head of Corporate Communications & Investor Relations Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Daniel Wendorff - Commerzbank Brian Weinstein - William Blair Scott Bardo - Berenberg Doug Schenkel - Cowen Steve Beuchaw - Wolfe Research Derik De Bruin - Bank of America Dan ...